Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥1.1bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥2.3bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥1.1bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income−¥84m2024-04-01 → 2024-09-30Cons.Operating income
Operating income−¥116m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income−¥78m2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income−¥168m2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥114m2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax−¥79m2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax−¥101m2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)−¥82m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥176m2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥104m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income−¥82m2024-04-01 → 2024-09-30Cons.Profit loss
Net income−¥104m2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥2.1bnat 2024-09-30Cons.Assets
Total assets¥1.7bnat 2024-03-31Cons.Assets
Total assets¥1.5bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥694mat 2024-09-30Cons.Liabilities
Total liabilities¥477mat 2024-03-31Cons.Liabilities
Net assets / equity¥1.4bnat 2024-09-30Cons.Net assets
Net assets / equity¥1.2bnat 2024-03-31Cons.Net assets
Net assets / equity¥1.1bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥190mat 2024-09-30Cons.Cash and deposits
Cash and deposits¥297mat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥190mat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥297mat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥238mat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥173mat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow−¥248m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥77m2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥54m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥432m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥87m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥6m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥573m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥288m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥126m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-1.382024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-3.312023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-22023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio65.9%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio71.2%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio72.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 32
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥59m
jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥500m
jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥500m
jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥10m
jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥439m
jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥439m
jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥2m
jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥181m
jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥181m
jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segmentsegment profit2024-04-01 → 2024-09-30−¥9m
jpcrp040300-q2r_E05674-000Sustainable Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥3m
jpcrp040300-q2r_E05674-000Sustainable Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥3m
jpcrp040300-q2r_E05674-000Sustainable Businessreportable segmentsegment profit2024-04-01 → 2024-09-30−¥29m
—segment totalrevenue2024-04-01 → 2024-09-30¥1.1bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥1.1bn
—segment totalsegment profit2024-04-01 → 2024-09-30−¥26m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥40m
jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥538m
jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥538m
jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥16m
jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥395m
jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥395m
jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segmentsegment profit2023-04-01 → 2023-09-30−¥56m
jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥168m
jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥168m
jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥1m
jpcrp040300-q2r_E05674-000Sustainable Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥3m
jpcrp040300-q2r_E05674-000Sustainable Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥3m
jpcrp040300-q2r_E05674-000Sustainable Businessreportable segmentsegment profit2023-04-01 → 2023-09-30−¥37m
—segment totalrevenue2023-04-01 → 2023-09-30¥1.1bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥1.1bn
—segment totalsegment profit2023-04-01 → 2023-09-30−¥76m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 489
ItemContextValueUnit
Interest and dividends income ope cfPrior1YTDDuration-5000JPY
Interest and dividends income ope cfCurrentYTDDuration-21000JPY
Interest expenses ope cfPrior1YTDDuration-JPY
Interest expenses ope cfCurrentYTDDuration1211000JPY
Stock issuance cost ope cfPrior1YTDDuration190000JPY
Stock issuance cost ope cfCurrentYTDDuration562000JPY
Gain on reversal of subscription rights to shares ope cfPrior1YTDDuration-11093000JPY
Gain on reversal of subscription rights to shares ope cfCurrentYTDDuration-JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration25511000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration67012000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-68552000JPY
Decrease increase in inventories ope cfCurrentYTDDuration24178000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration80756000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-102011000JPY
Decrease increase in accounts receivable other ope cfPrior1YTDDuration1570000JPY
Decrease increase in accounts receivable other ope cfCurrentYTDDuration480000JPY
Increase decrease in accounts payable other ope cfPrior1YTDDuration-4025000JPY
Increase decrease in accounts payable other ope cfCurrentYTDDuration-6437000JPY
Advance in allowance for doubtful accounts ope cfPrior1YTDDuration26489000JPY
Advance in allowance for doubtful accounts ope cfCurrentYTDDuration-24579000JPY
Increase decrease in contract liabilities ope cfPrior1YTDDuration-JPY
Increase decrease in contract liabilities ope cfCurrentYTDDuration-7212000JPY
Other net ope cfPrior1YTDDuration-19985000JPY
Other net ope cfCurrentYTDDuration-125100000JPY
Subtotal ope cfPrior1YTDDuration-49969000JPY
Subtotal ope cfCurrentYTDDuration-236359000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration5000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration21000JPY
Income taxes paid ope cfPrior1YTDDuration-8132000JPY
Income taxes paid ope cfCurrentYTDDuration-11829000JPY
Income taxes refund ope cfPrior1YTDDuration3735000JPY
Income taxes refund ope cfCurrentYTDDuration-JPY
Net cash provided by used in operating activitiesPrior1YTDDuration-54360000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration-248168000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration-6218000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-427265000JPY
Purchase of intangible assets inv cfPrior1YTDDuration-JPY
Purchase of intangible assets inv cfCurrentYTDDuration-1500000JPY
Proceeds from collection of lease and guarantee deposits inv cfPrior1YTDDuration326000JPY
Proceeds from collection of lease and guarantee deposits inv cfCurrentYTDDuration30000JPY
Payments for lease and guarantee deposits inv cfPrior1YTDDuration-121000JPY
Payments for lease and guarantee deposits inv cfCurrentYTDDuration-3000000JPY
Payments for asset retirement obligations inv cfPrior1YTDDuration-243000JPY
Payments for asset retirement obligations inv cfCurrentYTDDuration-JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-6257000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-431735000JPY
Increase in short term loans payable fin cfPrior1YTDDuration-JPY
Increase in short term loans payable fin cfCurrentYTDDuration330000000JPY
Proceeds from issuance of subscription rights to shares fin cfPrior1YTDDuration-JPY
Proceeds from issuance of subscription rights to shares fin cfCurrentYTDDuration3189000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass